Dronabinol
درونابینول
🍽️ Alimentary Tract And MetabolismCannabinoid (synthetic THC)
Market / country: 🇺🇸 USA
Marinol (US)
🧮 Dose calculator
AIDS-associated anorexia and weight loss · Regimen source: FDA Marinol · 2.1
- • Elderly or intolerant: 2.5 mg once before dinner or at bedtime. Max 10 mg twice daily. FDA Marinol · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ History of hypersensitivity to dronabinol or sesame oil. FDA Marinol · 4
Warnings
- • Neuropsychiatric reactions (confusion, euphoria, psychosis); haemodynamic instability; seizures; multiple substance abuse; paradoxical nausea and vomiting. FDA Marinol · 5
Formulations
- 2.5 mg capsule — capsule 🇺🇸 USA FDA Marinol · 3
- 5 mg capsule — capsule 🇺🇸 USA FDA Marinol · 3
- 10 mg capsule — capsule 🇺🇸 USA FDA Marinol · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Marinol · 8.1
“Risk Summary MARINOL, a synthetic cannabinoid, may cause fetal harm.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Marinol · 8.2
“Risk Summary For mothers infected with the Human Immunodeficiency Virus (HIV), the Centers for Disease Control and Prevention recommends that HIV-infected mothers not breastfeed their infants to avoid risking postnatal transmission of HIV.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Marinol · 8.4
“The safety and effectiveness of MARINOL have not been established in pediatric patients.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Marinol · 8.5
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of falls, decreased hepatic, renal, or cardiac function, increased sensitivity to psychoactive effects, and of concomitant disease or other drug therapy [see …”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA018651
- DailyMed (FDA label)FDA Marinol
- MedlinePlus (NIH)Dronabinol
- WHO ATC/DDDA04AD10
- Darooyab (Iran)Dronabinol
🇮🇷 Registered in Iran Darooyab · G-2578/Dronabinol
Dosage forms with Iranian generic codes, per Darooyab.
- 08121 · DRONABINOL 5MG TAB · قرص درونابینول ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Marinol · 3FDA Marinol · 2.1FDA Marinol · 2.2FDA Marinol · 4FDA Marinol · 5FDA Marinol · SPL approval / marketing categoryFDA Marinol · 8.1FDA Marinol · 8.2FDA Marinol · 8.4FDA Marinol · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2578/Dronabinol
- Clinical review⚠ Unverified